The BRD9/7 Inhibitor TP-472 Blocks Melanoma Tumor Growth by Suppressing ECM-Mediated Oncogenic Signaling and Inducing Apoptosis.

MLA

Mason, Lawrence David, et al. “The BRD9/7 Inhibitor TP-472 Blocks Melanoma Tumor Growth by Suppressing ECM-Mediated Oncogenic Signaling and Inducing Apoptosis.” Cancers, vol. 13, no. 21, Nov. 2021. EBSCOhost, https://doi.org/10.3390/cancers13215516.

APA

Mason, L. D., Chava, S., Reddi, K. K., & Gupta, R. (2021). The BRD9/7 Inhibitor TP-472 Blocks Melanoma Tumor Growth by Suppressing ECM-Mediated Oncogenic Signaling and Inducing Apoptosis. Cancers, 13(21). https://doi.org/10.3390/cancers13215516

Chicago

Mason, Lawrence David, Suresh Chava, Kiran Kumar Reddi, and Romi Gupta. 2021. “The BRD9/7 Inhibitor TP-472 Blocks Melanoma Tumor Growth by Suppressing ECM-Mediated Oncogenic Signaling and Inducing Apoptosis.” Cancers 13 (21). doi:10.3390/cancers13215516.